What You Need to Know about Lecanemab, the Potential New Alzheimer’s(03)

What You Need to Know about Lecanemab, the Potential New Alzheimer’s(03)


Image gallery: New Alzheimers Drug Reduces Cognitive Decline

New Alzheimer's drug Donanemab 35 slowing of cognitive decline? Study Shows New Alzheimer’s Drug Slows Cognitive Decline FDA Approves Leqembi, a New Alzheimer's Drug Lecanemab, AD What You Need to Know about Lecanemab, the Potential New Alzheimer’s New Study Finds Alzheimer’s Drug Donanemab Can Modestly Slow Memory